LionBird provides pre-scale capital and assistance exclusively to digital health startups in the pre-scale phase—defined as 'everything that comes before a ready to execute plan for marketing, selling and servicing customers in a repeatable way.' They focus on teams on a mission to fix healthcare through technology-enabled solutions.
| Fund Size | N/A USD |
| Stages Focus | Pre-Seed, Seed, Series A |
| Sectors Focus | Healthcare, Biotech, AI/ML |
| Portfolio Size | 0 companies |
LionBird believes in resetting healthcare’s relationship with technology by investing in pre-scale digital health startups that are engineered from unique insights to generate unnatural advantages. The firm aspires to be ‘the best pre-scale digital health investors out there’ by helping founders lay the best foundations for their companies to scale and succeed. Their approach is rooted in deep healthcare expertise, combining experience from Fortune 100 executives with veteran entrepreneurs who have founded, scaled, and taken companies public.
Active team contains 0 members (0 partners, 0 founders).